FDA Inspection 1270977 — Pfizer Ireland Pharmaceuticals Unlimited Company
The FDA completed an inspection of Pfizer Ireland Pharmaceuticals Unlimited Company on December 15, 2023 in Dublin 22. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 15, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dublin 22 (Ireland)
Additional Details
Mutual Recognition Agreement (MRA)